Influence of surgical 1 margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the ,
, AFC-IHCC-2009 study group, Ann Surg, vol.254, pp.824-830, 2011.
,
, Does Not Improve Survival in Multifocal Intrahepatic Cholangiocarcinoma: A Comparison of Surgical 5 Resection with Intra-Arterial Therapies, Ann Surg Oncol, vol.25, pp.83-90, 2018.
,
Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing 8 ,
, Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability, J Vasc Interv Radiol JVIR, vol.9, pp.1874-1878, 2015.
Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry 11 in the radioembolization of liver malignancies with (90)Y-loaded microspheres, Eur J Nucl Med Mol 12 Imaging, vol.43, pp.559-75, 2016. ,
Selective Internal Radiation Therapy (SIRT) with Yttrium-90-glass-microspheres 14 plus chemotherapy in first-line treatment of advanced cholangiocarcinoma (MISPHEC study) ,
Selective internal 17 radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic 18 cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial, Trials, vol.19, p.311, 2014. ,